Myrtle Potter

US Patent:

20190392539, Dec 26, 2019

Filed:

Sep 6, 2019

Appl. No.:

16/563471

Inventors:

Myrtle S. POTTER - Dunwoody GA, US

International Classification:

G06Q 50/22
G06Q 30/02

Abstract:

The present invention is directed to a brand value growth and retention system for brand drugs commercialized by brand drug advertisers through a brand drug's lifecycle during patent exclusivity and after loss of exclusivity. The brand value growth and retention system iteratively analyzes combined computational models of consumer, healthcare provider retailer and payor segment data to produce brand drug promotional campaigns that are predictive with modifying parameters that transform the promotional campaigns over time. As a result, the brand drug promotional campaign generates an increased number of brand drug purchases while predicting the point where incremental promotional campaign investments produce a diminishing number of incremental brand drug purchases.

US Patent:

20180174257, Jun 21, 2018

Filed:

Feb 20, 2018

Appl. No.:

15/900456

Inventors:

Myrtle S. POTTER - Dunwoody GA, US

International Classification:

G06Q 50/22
G06Q 30/02

Abstract:

The present invention is directed to a brand value growth and retention system for brand drugs commercialized by brand drug advertisers through a brand drug's lifecycle during patent exclusivity and after loss of exclusivity. The brand value growth and retention system iteratively analyzes combined computational models of consumer, healthcare provider retailer and payor segment data to produce brand drug promotional campaigns that are predictive with modifying parameters that transform the promotional campaigns over time. As a result, the brand drug promotional campaign generates an increased number of brand drug purchases while predicting the point where incremental promotional campaign investments produce a diminishing number of incremental brand drug purchases.

US Patent:

20140278507, Sep 18, 2014

Filed:

Mar 14, 2014

Appl. No.:

14/214636

Inventors:

Myrtle S. POTTER - Dunwoody GA, US

International Classification:

G06Q 50/22
G06Q 30/02

US Classification:

705 2

Abstract:

The present invention is directed to a brand value growth and retention system for brand drugs commercialized by brand drug advertisers through a brand drug's lifecycle during patent exclusivity and after loss of exclusivity. The brand value growth and retention system iteratively analyzes combined computational models of consumer, healthcare provider retailer and payor segment data to produce brand drug promotional campaigns that are predictive with modifying parameters that transform the promotional campaigns over time. As a result, the brand drug promotional campaign generates an increased number of brand drug purchases while predicting the point where incremental promotional campaign investments produce a diminishing number of incremental brand drug purchases.